PAREXEL named pharmaceutical company of the year
BOSTON — PAREXEL International Corporation, a global biopharmaceutical services provider, has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards, according to a press release.
The company, which announced strategic partnerships over the past year with Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck and Pfizer, was selected by an independent panel of internationally-based judges for transforming its business to deliver best-practice strategic partnering models that leverage its global resources and worldwide technology infrastructure.“We are honored to be recognized by the judges of The International Business Awards,” said Josef von Rickenbach, chairman and CEO of PAREXEL International. “This award is a tribute to the expertise of our employees who provide innovative solutions to help our clients accomplish their product development goals. We share a vision with our clients to bring healthcare improvements to patients around the world. All of us at PAREXEL are committed to advancing the success of the biopharmaceutical industry in our mission to prevent and cure disease.”